{"transactions":[{"id":3623243,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Restricted Stock Units","published_at":"2019-03-01T16:34:12.000Z","date":"2019-02-27","kind":"exercise","acquired":false,"shares":6945,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Fully vested as of the date hereof."}],"balance_after":13888,"derivative":{"exercise_price":0,"exercise_date":"2019-02-27","underlying":"Ordinary Shares","underlying_shares":6945},"source":{"system":"sec-edgar","filing":"0001209191-19-015000","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919119015000/doc4.xml","form_type":"4"}},{"id":3623242,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2019-03-01T16:34:12.000Z","date":"2019-02-27","kind":"exercise","acquired":true,"shares":6945,"price":52.9,"value":367390.5,"ownership":{"direct":true},"balance_after":152408,"source":{"system":"sec-edgar","filing":"0001209191-19-015000","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919119015000/doc4.xml","form_type":"4"}},{"id":3632649,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Restricted Stock Units","published_at":"2019-02-26T17:57:08.000Z","date":"2019-02-22","kind":"exercise","acquired":false,"shares":36400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Fully vested as of the date hereof."}],"balance_after":36399,"derivative":{"exercise_price":0,"exercise_date":"2019-02-22","underlying":"Ordinary Shares","underlying_shares":36400},"source":{"system":"sec-edgar","filing":"0001209191-19-013680","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919119013680/doc4.xml","form_type":"4"}},{"id":3632648,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2019-02-26T17:57:08.000Z","date":"2019-02-22","kind":"exercise","acquired":true,"shares":36400,"price":53.38,"value":1943032.0,"ownership":{"direct":true},"balance_after":145463,"source":{"system":"sec-edgar","filing":"0001209191-19-013680","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919119013680/doc4.xml","form_type":"4"}},{"id":3691897,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2019-01-18T16:13:31.000Z","date":"2019-01-17","kind":"exercise","acquired":false,"shares":68813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested and currently exercisable as of the date hereof."}],"balance_after":66522,"derivative":{"exercise_price":14.37,"expiration_date":"2025-02-23","underlying":"Ordinary Shares","underlying_shares":68813},"source":{"system":"sec-edgar","filing":"0001209191-19-004549","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919119004549/doc4.xml","form_type":"4"}},{"id":3691896,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2019-01-18T16:13:31.000Z","date":"2019-01-16","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested and currently exercisable as of the date hereof."}],"balance_after":135335,"derivative":{"exercise_price":14.37,"expiration_date":"2025-02-23","underlying":"Ordinary Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-19-004549","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919119004549/doc4.xml","form_type":"4"}},{"id":3691895,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2019-01-18T16:13:31.000Z","date":"2019-01-17","kind":"sale","acquired":false,"shares":68813,"price":45.25,"value":3113788.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On January 17, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 68,813 shares in multiple trades at prices ranging from $45.00 to $45.66.  The price reported above reflects the weighted average sale price.  Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":109063,"source":{"system":"sec-edgar","filing":"0001209191-19-004549","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919119004549/doc4.xml","form_type":"4"}},{"id":3691894,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2019-01-18T16:13:31.000Z","date":"2019-01-17","kind":"exercise","acquired":true,"shares":68813,"price":14.37,"value":988842.81,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson."}],"balance_after":177876,"source":{"system":"sec-edgar","filing":"0001209191-19-004549","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919119004549/doc4.xml","form_type":"4"}},{"id":3691893,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2019-01-18T16:13:31.000Z","date":"2019-01-16","kind":"sale","acquired":false,"shares":100000,"price":45.11,"value":4511000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On January 16, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 100,000 shares in multiple trades at prices ranging from $45.00 to $45.36.  The price reported above reflects the weighted average sale price.  Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":109063,"source":{"system":"sec-edgar","filing":"0001209191-19-004549","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919119004549/doc4.xml","form_type":"4"}},{"id":3691892,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2019-01-18T16:13:31.000Z","date":"2019-01-16","kind":"exercise","acquired":true,"shares":100000,"price":14.37,"value":1437000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson."}],"balance_after":209063,"source":{"system":"sec-edgar","filing":"0001209191-19-004549","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919119004549/doc4.xml","form_type":"4"}},{"id":3870364,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2018-07-10T16:11:54.000Z","date":"2018-07-06","kind":"grant","acquired":true,"shares":1231,"price":17.255,"value":21240.905,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2018 through June 30, 2018.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on January 2, 2018."}],"balance_after":109063,"source":{"system":"sec-edgar","filing":"0001209191-18-042137","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919118042137/doc4.xml","form_type":"4"}},{"id":3892631,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2018-06-15T16:24:48.000Z","date":"2018-06-13","kind":"exercise","acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options exercised were fully vested as of the date hereof."}],"balance_after":37500,"derivative":{"exercise_price":11.46,"expiration_date":"2026-02-24","underlying":"Ordinary Shares","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001209191-18-038050","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919118038050/doc4.xml","form_type":"4"}},{"id":3892630,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2018-06-15T16:24:48.000Z","date":"2018-06-13","kind":"exercise","acquired":true,"shares":30750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options exercised were fully vested as of the date hereof."}],"balance_after":235335,"derivative":{"exercise_price":14.37,"expiration_date":"2025-02-23","underlying":"Ordinary Shares","underlying_shares":30750},"source":{"system":"sec-edgar","filing":"0001209191-18-038050","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919118038050/doc4.xml","form_type":"4"}},{"id":3892629,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2018-06-15T16:24:48.000Z","date":"2018-06-13","kind":"exercise","acquired":true,"shares":37500,"price":11.46,"value":429750.0,"ownership":{"direct":true},"balance_after":107832,"source":{"system":"sec-edgar","filing":"0001209191-18-038050","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919118038050/doc4.xml","form_type":"4"}},{"id":3892628,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2018-06-15T16:24:48.000Z","date":"2018-06-13","kind":"exercise","acquired":true,"shares":30750,"price":14.37,"value":441877.5,"ownership":{"direct":true},"balance_after":70332,"source":{"system":"sec-edgar","filing":"0001209191-18-038050","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919118038050/doc4.xml","form_type":"4"}},{"id":3903488,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2018-06-06T17:28:05.000Z","date":"2018-06-04","kind":"exercise","acquired":true,"shares":68250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Options exercised were fully vested as of the date hereof."}],"balance_after":204750,"derivative":{"exercise_price":7.15,"expiration_date":"2027-02-21","underlying":"Ordinary Shares","underlying_shares":68250},"source":{"system":"sec-edgar","filing":"0001209191-18-036127","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919118036127/doc4.xml","form_type":"4"}},{"id":3903487,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2018-06-06T17:28:05.000Z","date":"2018-06-04","kind":"exercise","acquired":true,"shares":59130,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Options exercised were fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":7.48,"expiration_date":"2024-02-25","underlying":"Ordinary Shares","underlying_shares":59130},"source":{"system":"sec-edgar","filing":"0001209191-18-036127","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919118036127/doc4.xml","form_type":"4"}},{"id":3903486,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2018-06-06T17:28:05.000Z","date":"2018-06-04","kind":"exercise","acquired":true,"shares":218781,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Options exercised were fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":7.03,"expiration_date":"2023-02-19","underlying":"Ordinary Shares","underlying_shares":218781},"source":{"system":"sec-edgar","filing":"0001209191-18-036127","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919118036127/doc4.xml","form_type":"4"}},{"id":3903485,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2018-06-06T17:28:05.000Z","date":"2018-06-04","kind":"sale","acquired":false,"shares":4131,"price":31.74,"value":131117.94,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On June 4, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 4,131 shares in multiple trades at prices ranging from $31.00 to $31.99.  The price reported above reflects the weighted average sale price.  Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":39582,"source":{"system":"sec-edgar","filing":"0001209191-18-036127","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919118036127/doc4.xml","form_type":"4"}},{"id":3903484,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2018-06-06T17:28:05.000Z","date":"2018-06-04","kind":"sale","acquired":false,"shares":1800,"price":30.26,"value":54468.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On June 4, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 1,800 shares in multiple trades at prices ranging from $30.00 to $30.99.  The price reported above reflects the weighted average sale price.  Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":43713,"source":{"system":"sec-edgar","filing":"0001209191-18-036127","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919118036127/doc4.xml","form_type":"4"}},{"id":3903483,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2018-06-06T17:28:05.000Z","date":"2018-06-04","kind":"sale","acquired":false,"shares":114934,"price":29.36,"value":3374462.24,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On June 4, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 114,934 shares in multiple trades at prices ranging from $29.00 to $29.99.  The price reported above reflects the weighted average sale price.  Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":45513,"source":{"system":"sec-edgar","filing":"0001209191-18-036127","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919118036127/doc4.xml","form_type":"4"}},{"id":3903482,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2018-06-06T17:28:05.000Z","date":"2018-06-04","kind":"exercise","acquired":true,"shares":68250,"price":7.15,"value":487987.5,"ownership":{"direct":true},"balance_after":160447,"source":{"system":"sec-edgar","filing":"0001209191-18-036127","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919118036127/doc4.xml","form_type":"4"}},{"id":3903481,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2018-06-06T17:28:05.000Z","date":"2018-06-04","kind":"exercise","acquired":true,"shares":59130,"price":7.48,"value":442292.4,"ownership":{"direct":true},"balance_after":92197,"source":{"system":"sec-edgar","filing":"0001209191-18-036127","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919118036127/doc4.xml","form_type":"4"}},{"id":3903480,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2018-06-06T17:28:05.000Z","date":"2018-06-04","kind":"sale","acquired":false,"shares":225296,"price":28.6,"value":6443465.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 4, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 225,296 shares in multiple trades at prices ranging from $28.00 to $28.99.  The price reported above reflects the weighted average sale price.  Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":33067,"source":{"system":"sec-edgar","filing":"0001209191-18-036127","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919118036127/doc4.xml","form_type":"4"}},{"id":3903479,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2018-06-06T17:28:05.000Z","date":"2018-06-04","kind":"exercise","acquired":true,"shares":218781,"price":7.03,"value":1538030.43,"ownership":{"direct":true},"balance_after":258363,"source":{"system":"sec-edgar","filing":"0001209191-18-036127","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919118036127/doc4.xml","form_type":"4"}},{"id":3959344,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2018-04-20T16:53:34.000Z","date":"2018-04-18","kind":"exercise","acquired":true,"shares":70956,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":3.44,"exercise_date":"2021-12-31","underlying":"Ordinary Shares","underlying_shares":70956},"source":{"system":"sec-edgar","filing":"0001209191-18-025732","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919118025732/doc4.xml","form_type":"4"}},{"id":3959343,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2018-04-20T16:53:34.000Z","date":"2018-04-18","kind":"exercise","acquired":true,"shares":76869,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":3.44,"exercise_date":"2021-09-14","underlying":"Ordinary Shares","underlying_shares":76869},"source":{"system":"sec-edgar","filing":"0001209191-18-025732","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919118025732/doc4.xml","form_type":"4"}},{"id":3959342,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2018-04-20T16:53:34.000Z","date":"2018-04-18","kind":"sale","acquired":false,"shares":70956,"price":24,"value":1702944.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson."}],"balance_after":39582,"source":{"system":"sec-edgar","filing":"0001209191-18-025732","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919118025732/doc4.xml","form_type":"4"}},{"id":3959341,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2018-04-20T16:53:34.000Z","date":"2018-04-18","kind":"exercise","acquired":true,"shares":70956,"price":3.44,"value":244088.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson."}],"balance_after":110538,"source":{"system":"sec-edgar","filing":"0001209191-18-025732","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919118025732/doc4.xml","form_type":"4"}},{"id":3959340,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2018-04-20T16:53:34.000Z","date":"2018-04-18","kind":"sale","acquired":false,"shares":76869,"price":24,"value":1844856.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson."}],"balance_after":39582,"source":{"system":"sec-edgar","filing":"0001209191-18-025732","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919118025732/doc4.xml","form_type":"4"}},{"id":3959339,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2018-04-20T16:53:34.000Z","date":"2018-04-18","kind":"exercise","acquired":true,"shares":76869,"price":3.44,"value":264429.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson."}],"balance_after":116451,"source":{"system":"sec-edgar","filing":"0001209191-18-025732","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919118025732/doc4.xml","form_type":"4"}},{"id":4023963,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-03-01T16:21:22.000Z","date":"2018-02-27","kind":"grant","acquired":true,"shares":20833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive, at settlement, one (1) ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third of these restricted stock units are scheduled to vest on each of February 27, 2019, 2020 and 2021, subject to the reporting person's continued employment through such dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-third of these restricted stock units are scheduled to vest on each of February 27, 2019, 2020 and 2021, subject to the reporting person's continued employment through such dates."}],"balance_after":20833,"derivative":{"underlying":"Ordinary Shares","underlying_shares":20833},"source":{"system":"sec-edgar","filing":"0001209191-18-015010","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919118015010/doc4.xml","form_type":"4"}},{"id":4023962,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2018-03-01T16:21:22.000Z","date":"2018-02-27","kind":"grant","acquired":true,"shares":152068,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to buy 152,068 ordinary shares will vest and become exercisable in equal installments on each of February 27, 2019, 2020, 2021 and 2022, subject to the reporting person's continued employment through such dates."}],"balance_after":152068,"derivative":{"exercise_price":21.15,"expiration_date":"2028-02-27","underlying":"Ordinary Shares","underlying_shares":152068},"source":{"system":"sec-edgar","filing":"0001209191-18-015010","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919118015010/doc4.xml","form_type":"4"}},{"id":4033993,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Restricted Stock Units","published_at":"2018-02-26T17:10:50.000Z","date":"2018-02-22","kind":"exercise","acquired":true,"shares":36401,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Fully vested as of the date hereof."}],"balance_after":72799,"derivative":{"exercise_price":0,"exercise_date":"2018-02-22","underlying":"Ordinary Shares","underlying_shares":36401},"source":{"system":"sec-edgar","filing":"0001209191-18-013425","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919118013425/doc4.xml","form_type":"4"}},{"id":4033992,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2018-02-26T17:10:50.000Z","date":"2018-02-22","kind":"exercise","acquired":true,"shares":36401,"price":21.55,"value":784441.55,"ownership":{"direct":true},"balance_after":39582,"source":{"system":"sec-edgar","filing":"0001209191-18-013425","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919118013425/doc4.xml","form_type":"4"}},{"id":4099383,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2018-01-16T17:01:59.000Z","date":"2018-01-11","kind":"sale","acquired":false,"shares":25320,"price":22.0034,"value":557126.088,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On January 11, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 25,320 shares in multiple trades at prices ranging from $22.00 to $22.10.  The price reported above reflects the weighted average sale price.  Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":3181,"source":{"system":"sec-edgar","filing":"0001209191-18-003629","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919118003629/doc4.xml","form_type":"4"}},{"id":4168967,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2017-11-08T16:15:48.000Z","date":"2017-11-06","kind":"sale","acquired":false,"shares":9100,"price":22,"value":200200.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson."}],"balance_after":28501,"source":{"system":"sec-edgar","filing":"0001209191-17-059742","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919117059742/doc4.xml","form_type":"4"}},{"id":4171466,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2017-11-06T16:18:12.000Z","date":"2017-11-03","kind":"sale","acquired":false,"shares":3100,"price":22,"value":68200.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson."}],"balance_after":37601,"source":{"system":"sec-edgar","filing":"0001209191-17-059404","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919117059404/doc4.xml","form_type":"4"}},{"id":4171465,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2017-11-06T16:18:12.000Z","date":"2017-11-02","kind":"sale","acquired":false,"shares":300,"price":22,"value":6600.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson."}],"balance_after":40701,"source":{"system":"sec-edgar","filing":"0001209191-17-059404","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919117059404/doc4.xml","form_type":"4"}},{"id":4174640,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2017-11-02T16:22:13.000Z","date":"2017-11-01","kind":"sale","acquired":false,"shares":22119,"price":22.0087,"value":486810.4353,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On November 1, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 22,119 shares in multiple trades at prices ranging from $22.00 to $22.10.  The price reported above reflects the weighted average sale price.  Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":41001,"source":{"system":"sec-edgar","filing":"0001209191-17-058849","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919117058849/doc4.xml","form_type":"4"}},{"id":4174639,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2017-11-02T16:22:13.000Z","date":"2017-10-31","kind":"sale","acquired":false,"shares":150,"price":22,"value":3300.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson."}],"balance_after":63120,"source":{"system":"sec-edgar","filing":"0001209191-17-058849","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919117058849/doc4.xml","form_type":"4"}},{"id":4200942,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2017-09-27T16:19:27.000Z","date":"2017-09-25","kind":"disposition_to_issuer","acquired":false,"shares":1900,"price":22.0342,"value":41864.98,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 25, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 1,900 shares in multiple trades at prices ranging from $22.00 to $22.05.  The price reported above reflects the weighted average sale price.  Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":63270,"source":{"system":"sec-edgar","filing":"0001209191-17-054126","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919117054126/doc4.xml","form_type":"4"}},{"id":4208382,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2017-09-15T16:09:39.000Z","date":"2017-09-14","kind":"disposition_to_issuer","acquired":false,"shares":2500,"price":22.032,"value":55080.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On September 14, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 2,500 shares in multiple trades at prices ranging from $22.00 to $22.25.  The price reported above reflects the weighted average sale price.  Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":65170,"source":{"system":"sec-edgar","filing":"0001209191-17-052952","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919117052952/doc4.xml","form_type":"4"}},{"id":4208381,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2017-09-15T16:09:39.000Z","date":"2017-09-13","kind":"disposition_to_issuer","acquired":false,"shares":46872,"price":22.0124,"value":1031765.2128,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 13, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 46,872 shares in multiple trades at prices ranging from $22.00 to $22.10.  The price reported above reflects the weighted average sale price.  Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":67670,"source":{"system":"sec-edgar","filing":"0001209191-17-052952","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919117052952/doc4.xml","form_type":"4"}},{"id":4260916,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2017-07-07T16:40:17.000Z","date":"2017-07-05","kind":"disposition_to_issuer","acquired":false,"shares":111361,"price":18.144,"value":2020533.984,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On July 5, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 111,361 shares in multiple trades at prices ranging from $18.00 to $18.35.  The price reported above reflects the weighted average sale price.  Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":114542,"source":{"system":"sec-edgar","filing":"0001209191-17-044395","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919117044395/doc4.xml","form_type":"4"}},{"id":4260915,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2017-07-07T16:40:17.000Z","date":"2017-07-05","kind":"grant","acquired":true,"shares":3181,"price":6.673,"value":21226.813,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2017 through June 30, 2017.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on January 3, 2017."}],"balance_after":225903,"source":{"system":"sec-edgar","filing":"0001209191-17-044395","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919117044395/doc4.xml","form_type":"4"}},{"id":4274620,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2017-06-22T16:29:26.000Z","date":"2017-06-21","kind":"sale","acquired":false,"shares":66361,"price":16.775,"value":1113205.775,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 21, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 66,361 shares in multiple trades at prices ranging from $16.60 to $17.50.  The price reported above reflects the weighted average sale price.  Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":222722,"source":{"system":"sec-edgar","filing":"0001209191-17-041382","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919117041382/doc4.xml","form_type":"4"}},{"id":4275305,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2017-06-21T16:19:09.000Z","date":"2017-06-19","kind":"sale","acquired":false,"shares":15000,"price":15.059,"value":225885.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 19, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 15,000 shares in multiple trades at prices ranging from $15.00 to $15.20.  The price reported above reflects the weighted average sale price.  Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":289083,"source":{"system":"sec-edgar","filing":"0001209191-17-041202","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919117041202/doc4.xml","form_type":"4"}},{"id":4280883,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2017-06-15T16:28:08.000Z","date":"2017-06-13","kind":"sale","acquired":false,"shares":9044,"price":15.012,"value":135768.528,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 13, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 9,044 shares in multiple trades at prices ranging from $15.00 to $15.10.  The price reported above reflects the weighted average sale price.  Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":304083,"source":{"system":"sec-edgar","filing":"0001209191-17-040155","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919117040155/doc4.xml","form_type":"4"}},{"id":4283912,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2017-06-13T18:19:11.000Z","date":"2017-06-12","kind":"sale","acquired":false,"shares":5956,"price":15.082,"value":89828.392,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On June 12, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 5,956 shares in multiple trades at prices ranging from $15.00 to $15.225.  The price reported above reflects the weighted average sale price.  Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":313127,"source":{"system":"sec-edgar","filing":"0001209191-17-039655","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919117039655/doc4.xml","form_type":"4"}},{"id":4283911,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Ordinary Shares","published_at":"2017-06-13T18:19:11.000Z","date":"2017-06-09","kind":"sale","acquired":false,"shares":15000,"price":15.015,"value":225225.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 9, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 15,000 shares in multiple trades at prices ranging from $15.00 to $15.10.  The price reported above reflects the weighted average sale price.  Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":319083,"source":{"system":"sec-edgar","filing":"0001209191-17-039655","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000120919117039655/doc4.xml","form_type":"4"}},{"id":4424764,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief  Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2017-02-24T16:09:59.000Z","date":"2017-02-22","kind":"grant","acquired":true,"shares":109200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each  restricted stock unit represents the right to receive, at settlement, one (1) ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third of these restricted stock units are scheduled to vest on each of February 22, 2018, February 22, 2019, and February 22, 2020, subject to Mr. Kirson's continued employment through such dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-third of these restricted stock units are scheduled to vest on each of February 22, 2018, February 22, 2019, and February 22, 2020, subject to Mr. Kirson's continued employment through such dates."}],"balance_after":109200,"derivative":{"underlying":"Ordinary Shares","underlying_shares":109200},"source":{"system":"sec-edgar","filing":"0000899243-17-005227","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000089924317005227/doc4.xml","form_type":"4"}},{"id":4424763,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief  Scientific Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2017-02-24T16:09:59.000Z","date":"2017-02-22","kind":"grant","acquired":true,"shares":273000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to buy 273,000 ordinary shares will vest and become exercisable in equal installments on each of February 22, 2018, 2019, 2020 and 2021, subject to Mr. Kirson's continued employment through such dates."}],"balance_after":273000,"derivative":{"exercise_price":7.15,"expiration_date":"2027-02-22","underlying":"Ordinary Shares","underlying_shares":273000},"source":{"system":"sec-edgar","filing":"0000899243-17-005227","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000089924317005227/doc4.xml","form_type":"4"}},{"id":4531446,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief  Scientific Officer"}}],"security":"Options to buy Ordinary Shares","published_at":"2016-12-06T16:05:38.000Z","date":"2016-12-05","kind":"exercise","acquired":false,"shares":156073,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested and currently exercisable as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":0.17,"expiration_date":"2016-12-12","underlying":"Ordinary Shares","underlying_shares":156073},"source":{"system":"sec-edgar","filing":"0000899243-16-034974","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000089924316034974/doc4.xml","form_type":"4"}},{"id":4531445,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":159689,"kind":"person","name":"Kirson Eilon D.","position":1,"cik":"0001654356","reported_name":"Kirson Eilon D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief  Scientific Officer"}}],"security":"Ordinary Shares","published_at":"2016-12-06T16:05:38.000Z","date":"2016-12-05","kind":"exercise","acquired":true,"shares":156073,"price":0.17,"value":26532.41,"ownership":{"direct":true},"balance_after":334083,"source":{"system":"sec-edgar","filing":"0000899243-16-034974","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654356/000089924316034974/doc4.xml","form_type":"4"}}]}